Litchfield Hills Research Starts DarioHealth Corp. (DRIO) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts DRIO Hot Sheet
Price: $6.02 +3.79%
Rating Summary:
8 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 19 | New: 65
Rating Summary:
8 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 19 | New: 65
Join SI Premium – FREE
Litchfield Hills Research analyst Theodore O\'Neill initiates coverage on DarioHealth Corp. (NASDAQ: DRIO) with a Buy rating and a price target of $3.00.
For an analyst ratings summary and ratings history on DarioHealth Corp. click here. For more ratings news on DarioHealth Corp. click here.
Shares of DarioHealth Corp. closed at $0.66 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Starts Delek US (DK) at Hold
- Skydance names new board after Paramount-Warner Bros. merger
- William Blair Downgrades Option Care Health (OPCH) to Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
